Lidocaine is the monocarboxylic acid amide resulting from the formal condensation of N,N-diethyl glycine with 2,6-dimethylaniline. It has a role as a local anaesthetic, an anti-arrhythmia drug, an environmental contaminant, a xenobiotic and a drug allergen. It is a monocarboxylic acid amide, a tertiary amino compound and a member of benzenes. It is functionally related to a glycinamide.
||2-(Diethylamino)-2′,6′-acetoxylidide; 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide; Anestacon; Aritmal; Cuivasil; Dalcaine; Duncaine; ELA-Max; Esracaine; Isicaina; Isicaine; Jetocaine; LMX; Leostesin; Lida-Mantle; LidoPosterine; Lidocadren; Lidocaine; Lidoderm; Lignocaine; Linisol; Maricaine; Medicaine; NSC 40030; Penles; Remicaine; Rucaina; Solarcaine; Solcain; Trachisan; Versatis; Xilina; Xybrex; Xycaine; Xylestesin; Xyline; Xylocain; Xylocaine; Xylocitin; Xylovet; α-Diethylamino-2,6-acetoxylidide;
||Lidocaine is an Anesthetic (local); antiarrhythmic (class IB). Long-acting, membrane stabilizing agent against ventricular arrhythmia. Originally developed as a local anesthetic. Neuroprotective & Neuroresearch Products.